bioAffinity Technologies, Inc.
BIAF
$0.83
-$0.01-1.23%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.63M | -3.14M | -5.05M | -4.06M | -2.66M |
| Total Depreciation and Amortization | 114.50K | 123.70K | 113.40K | 113.20K | 154.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.30K | 66.10K | 2.81M | 1.27M | 326.60K |
| Change in Net Operating Assets | 274.50K | 388.10K | -357.20K | 25.90K | 537.40K |
| Cash from Operations | -3.23M | -2.56M | -2.48M | -2.65M | -1.64M |
| Capital Expenditure | -5.70K | 0.00 | 3.60K | -13.40K | -50.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.70K | 0.00 | 3.60K | -13.40K | -50.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -118.50K | -106.70K | 43.10K | -167.00K | -139.20K |
| Issuance of Common Stock | -- | 1.80M | 9.73M | 3.19M | 1.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 990.00K | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -353.50K | -1.42M | -- | -- |
| Cash from Financing | -118.50K | 1.34M | 9.34M | 3.02M | 1.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.35M | -1.22M | 6.87M | 358.10K | -660.60K |